Medical Research
GeoVax's Multi-Antigen COVID-19 Vaccine Shows Strong Immune Response in Immunocompromised Patients
GeoVax Labs' GEO-CM04S1 vaccine demonstrates robust immunity in high-risk patients with blood cancers, potentially addressing a multi-billion dollar market where current vaccines have limited effectiveness.
Neuroscience Breakthrough Offers New Hope for Locked-In Syndrome Patients and Consciousness Research
Dr. Berenika Maciejewicz's research provides a new diagnostic framework for detecting consciousness in locked-in syndrome patients, with significant implications for brain-computer interfaces and neurological care.
Kairos Pharma to Host Key Opinion Leader Event on Phase 2 Prostate Cancer Trial Results
Kairos Pharma will present interim efficacy results from its Phase 2 trial of ENV105 in advanced prostate cancer, potentially addressing critical drug resistance challenges in oncology treatment.
Sigyn Therapeutics Appoints Dr. Christoph Zaba to Scientific Advisory Board to Advance Dialysis-Like Cardiovascular Therapy
Sigyn Therapeutics has appointed Dr. Christoph Zaba, an expert in extracorporeal therapies, to its Scientific Advisory Board to support the development of Sigyn Therapy™, a novel treatment designed to reduce cardiovascular disease risk factors using existing dialysis infrastructure.
NanoViricides to Present Broad-Spectrum Antiviral Platform at LSX World Congress 2025
NanoViricides will showcase its clinical-stage nanoviricide technology targeting multiple viral diseases at the LSX World Congress, highlighting its potential to address unmet medical needs through a novel antiviral approach.
Soligenix Expands Rare Disease and Public Health Pipeline in Latest Corporate Strategy Update
Soligenix Inc. showcases its dual-focused strategy addressing both rare diseases with unmet medical needs and critical public health threats through its latest corporate presentation, positioning the company as a significant player in specialized therapeutics and biodefense solutions.
Gyre Therapeutics Advances Hydronidone Toward China Approval and Expands Clinical Pipeline
Gyre Therapeutics has submitted Hydronidone for approval in China and initiated a U.S. Phase 2 trial, positioning the company for significant growth in liver fibrosis treatment markets.
WHAM Edge Awards 2025 to Fund Early-Career Researchers in Women's Health
The WHAM Edge Awards provide critical $25,000 grants to early-career researchers investigating how biological sex influences health outcomes, addressing systemic funding gaps and economic disparities in women's health research.
Study Reveals Only 14% of Online Blood Pressure Images Show Correct Measurement Technique
New research finds that just 1 in 7 online stock images accurately depict proper blood pressure measurement techniques, potentially leading to widespread incorrect readings and treatment decisions.
GeoVax's Multi-Antigen COVID-19 Vaccine Shows Promise for Immunocompromised Patients
GeoVax Labs will present clinical data demonstrating that its GEO-CM04S1 vaccine generates cross-variant antibody and robust cellular immune responses in immunocompromised patients with hematologic malignancies, potentially addressing a critical gap in COVID-19 protection for vulnerable populations.
National Survey Reveals Nearly Half of US Adults Experience Unexplained or Treatment-Resistant Pain and Illness
A groundbreaking national survey to be presented at the Association for the Treatment of Neuroplastic Symptoms conference shows that 40% of Americans seeking medical care have symptoms likely caused by stress-induced neural pathway changes rather than structural issues.
Childhood High Blood Pressure Linked to 40-50% Higher Risk of Early Cardiovascular Death
New research reveals that children with elevated blood pressure at age 7 face significantly increased risk of premature cardiovascular death by mid-50s, highlighting the critical importance of early blood pressure monitoring and heart-healthy habits.
New Medication Baxdrostat Shows Promise in Lowering Blood Pressure and Slowing Kidney Disease Progression
The novel medication baxdrostat demonstrated significant reductions in systolic blood pressure and urine albumin levels in patients with chronic kidney disease and uncontrolled hypertension, potentially offering new treatment options for this high-risk population.
NCI Ends 26-Year Funding for Pediatric Brain Cancer Research Consortium
The National Cancer Institute's termination of funding for a long-running pediatric brain cancer research program highlights growing reliance on private sector entities like CNS Pharmaceuticals Inc. to advance critical childhood cancer treatments.
Chiropractic Study Shows Non-Surgical Recovery From Severe Disc Injuries
A new study published in the Journal of Contemporary Chiropractic demonstrates that non-surgical chiropractic care can effectively manage massive lumbar disc herniations, offering a conservative alternative to invasive surgical treatments.
Kairos Pharma to Present Initial Phase 1 Data for ENV105 Lung Cancer Treatment at World Conference
Kairos Pharma Ltd. will present initial Phase 1 data for its ENV105 combination therapy targeting drug-resistant non-small cell lung cancer at the World Lung Cancer Conference, potentially addressing significant unmet medical needs in oncology treatment.
InFlectis BioScience and Aix Marseille Université Expand IFB-088's Therapeutic Potential to Axonal Charcot-Marie-Tooth Disease
InFlectis BioScience and Aix Marseille Université have demonstrated that lead compound IFB-088 shows efficacy in animal models of axonal Charcot-Marie-Tooth disease type 2A, expanding its potential to address multiple CMT subtypes with no approved treatments.
New Research Reveals 62% of AFib Patients Unaware of Condition Before Diagnosis
A new American Heart Association study shows most atrial fibrillation patients were unaware of their condition before diagnosis, highlighting critical gaps in public awareness about this serious heart rhythm disorder that significantly increases stroke risk.
Study Links Self-Medicating with Cannabis to Increased Paranoia Risk
New research indicates that individuals using marijuana to cope with depression, anxiety, or pain face higher paranoia risks compared to recreational users, while licensed operators may help reduce associated stigma.
Study Links Head Injuries to Increased Brain Cancer Risk, Driving Treatment Research
A Mass General Brigham study of 75,000 patients reveals traumatic brain injuries elevate malignant brain tumor risk, highlighting the importance of ongoing treatment development by companies like CNS Pharmaceuticals Inc.
Zevra Therapeutics to Present New MIPLYFFA Data at International Congress, Including Best Poster Award Winner
Zevra Therapeutics will present four posters on MIPLYFFA (arimoclomol) at the International Congress of Inborn Errors of Metabolism, including a Best Poster award-winning presentation detailing its mechanism of action for treating Niemann-Pick disease type C, highlighting significant advancements in rare disease treatment.
New PREVENT Equations Transform Cardiovascular Risk Assessment and Personalize Hypertension Treatment
The American Heart Association's PREVENT equations provide more accurate cardiovascular disease risk predictions, enabling personalized treatment decisions for adults with high blood pressure while addressing concerns about overtreatment.
University of Utah Study Identifies Mechanism Behind Blood Clot Risk in IBD Patients
New research from the University of Utah reveals why inflammatory bowel disease patients face elevated blood clot risks and suggests potential dual-treatment approaches that could address both clotting and inflammation.
MyBioSource Launches Validated Anti-CALB2 Antibody for Neuroscience Research
MyBioSource has introduced a validated sheep anti-rat calretinin polyclonal antibody that enables advanced research into calcium signaling, neuroprotection, and neurodegeneration across multiple species.
Soligenix Advances Rare Disease Pipeline with Key Clinical Milestones Expected Through 2026
Soligenix Inc. reports significant progress in its late-stage rare disease treatments, including pivotal Phase 3 cancer trial results due in 2026 and multiple fast-tracked therapies that could transform care for underserved patient populations.
World Heart Federation Honors American Heart Association CEO with Lifetime Achievement Award
Nancy Brown receives global recognition for her transformative leadership in advancing cardiovascular health worldwide through scientific innovation and quality improvement initiatives.
Blocking Brain Damage from Glioblastoma May Slow Tumor Growth and Extend Cognitive Function
New research from University College London suggests that preventing brain damage caused by glioblastoma could significantly slow tumor progression and preserve cognitive function longer in patients.
New Podcast Explores Neuroplastic Pain Affecting 1.5 Billion People Worldwide
Dr. David Clarke's podcast 'The Story Behind the Symptoms' addresses the growing epidemic of neuroplastic pain conditions through patient interviews and evidence-based Neuroplastic Recovery Therapy, offering alternatives to traditional medical treatments.
Boone Heart Institute to Host Summit Conference 2025 Focused on Preventive Cardiology Advancements
The Boone Heart Institute's Summit Conference 2025 in Denver will bring together healthcare professionals to address atherosclerosis, the world's leading cause of death, through cutting-edge research and clinical innovations in preventive cardiology.
Creative Biolabs Launches Integrated Cell Therapy Platforms to Advance Cancer Immunotherapy
Creative Biolabs has launched fully integrated CAR-T and TIL therapy development platforms, providing researchers and biotech startups with comprehensive services to accelerate the development of next-generation cellular immunotherapies for cancer treatment.